|NIDA Launches Centers of Excellence for Drug
The National Institute on Drug Abuse (NIDA), part of the National
Institutes of Health (NIH), today announced the establishment of
four Centers of Excellence for Physician Information — these
Centers will serve as national models to support the advancement
of addiction awareness, prevention, and treatment in primary care
practices. The NIDA Centers of Excellence (NIDA COEs) will target
physicians-in-training, including medical students and resident
physicians in primary care specialties (e.g., internal medicine,
family practice, and pediatrics).
The NIDA COEs are being developed in collaboration with the American
Medical Association’s (AMA) Research Consortium and are part of
NIDA’s ongoing Physician Outreach Program. The NIDA COEs will identify
drug addiction knowledge gaps, develop educational materials and
resources specifically designed for physicians in training to address
those gaps, and determine the most effective means of delivering
this information. As a result, the COEs seek to raise the awareness
among primary care physicians of drug addiction as a health issue
and to further facilitate the dissemination of knowledge on how
best to prevent, diagnose, and treat patients struggling with prescription
and illicit drug abuse.
“These new Centers of Excellence are just one step in a broad
cooperative effort to increase awareness among primary care physicians
and other health professionals, as well as patients, about drug
addiction as a major public health issue,” said NIH Director Dr.
Elias A. Zerhouni.
NIDA is establishing the Centers at academic medical institutions
across the country. The NIDA COEs for 2007 will be located at Creighton
University School of Medicine, Omaha, Nebraska; the University
of Pennsylvania School of Medicine in collaboration with Drexel
University College of Medicine; the University of North Dakota
School of Medicine and Health Sciences; and the Massachusetts Consortium
of Medical Schools, including the University of Massachusetts Medical
School, Tufts University School of Medicine, Boston University
School of Medicine, and Harvard Medical School/Cambridge Health
Alliance. The NIDA COEs will focus on a variety of areas, including
prescription drug abuse, methamphetamine abuse and addiction, co
morbid substance abuse and mental illness, and other issues related
to drug abuse.
“This AMA-NIDA collaboration is part of NIDA’s ongoing activities
to provide physicians and other medical professionals with the
tools and skills needed to incorporate NIDA-funded research findings
into their clinical practice,” said NIDA Director Dr. Nora D. Volkow.
The National Institute on Drug Abuse is a component of the
National Institutes of Health, U.S. Department of Health and
Human Services. NIDA supports most of the world’s research on
the health aspects of drug abuse and addiction. The Institute
carries out a large variety of programs to ensure the rapid dissemination
of research information and its implementation in policy and
practice. Fact sheets on the health effects of drugs of abuse
and information on NIDA research and other activities can be
found on the NIDA home page at www.drugabuse.gov.
The National Institutes of Health (NIH) — The Nation's
Medical Research Agency — includes 27 Institutes and
Centers and is a component of the U.S. Department of Health and
Human Services. It is the primary federal agency for conducting
and supporting basic, clinical and translational medical research,
and it investigates the causes, treatments, and cures for both
common and rare diseases. For more information about NIH and
its programs, visit www.nih.gov.